# Small Bone Innovations

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/small-bone-innovations

- Industry: Healthcare
- Headquarters: Morrisville, US
- Website: www.totalsmallbone.com
- Total disclosed funding: $166M
- Latest round: Series F (Dec 17, 2010)
- Investors on record: 10

## About

Small Bone Innovations, Inc. specializes in innovative orthopedic products, particularly focusing on solutions for small bone and joint surgery, catering to healthcare providers to enhance surgical outcomes.Small Bone Innovations, Inc. was founded in 2004 and is headquartered in Morrisville, US. The company focuses on developing advanced solutions for orthopedic surgery. In June 2014, Stryker Corporation acquired select assets of the firm for USD 375 mn. The current CEO is Anthony Viscogliosi, who has a background in technology and product development within the medical field.The company offers a suite of innovative products addressing orthopedic challenges, with core offerings that enhance operational efficiencies in surgical procedures. Its clientele includes mid-sized enterprises and large corporations, particularly in North America, Europe, and Asia. The flagship product launched in 2021 has streamlined processes for optimizing workflows in medical settings.The company's revenue is primarily from B2B transactions through direct sales. Business transactions involve annual subscriptions for software solutions, providing ongoing access to updates and customer support. Pricing plans are tiered, allowing businesses to choose options that suit their operational needs, fostering long-term partnerships and a steady revenue stream.Looking ahead, Small Bone Innovations, Inc. plans to expand its product line, with upcoming releases set to enhance its offerings in orthopedic solutions. The company aims to enter new markets in Asia and Europe by 2025. The recent funding of USD 375 mn from the acquisition by Stryker Corporation will be utilized to support these initiatives, focusing on product development and market expansion.

## Funding rounds

- Series F, Dec 17, 2010, $15M — NGN Capital, Khazanah Nasional Berhad, Viscogliosi Brothers
- Series D, Apr 1, 2009, $73M — 3i, NGN Capital, The Family Office, Trevi Health Ventures, Goldman Sachs Asset Management, Viscogliosi Brothers
- Series C, Jan 1, 2008, $36M — 3i, TGap Ventures, NGN Capital, Axiom Venture Partners, Trevi Health Ventures, Viscogliosi Brothers
- Series B, Dec 16, 2005, $42M — 3i, TGap Ventures, NGN Capital, Axiom Venture Partners, Anspach Investments, LLC, Viscogliosi Brothers

## Investors

- 3i (https://capitalatlas.ai/funds/3i) — Series B, Series C, Series D
- TGap Ventures (https://capitalatlas.ai/funds/tgap-ventures) — Series B, Series C
- NGN Capital (https://capitalatlas.ai/funds/ngn-capital) — Series B, Series C, Series D, Series F
- Axiom Venture Partners (https://capitalatlas.ai/funds/axiom-venture-partners) — Series B, Series C
- Anspach Investments, LLC — Series B
- Viscogliosi Brothers (https://capitalatlas.ai/funds/viscogliosi-brothers) — Series B, Series C, Series D, Series F
- Trevi Health Ventures (https://capitalatlas.ai/funds/trevi-health-ventures) — Series C, Series D
- The Family Office — Series D
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series D
- Khazanah Nasional Berhad — Series F